Dunhill Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Dunhill Financial's BMY Position: Q3 2026 in Review
Dunhill Financial reduced its Bristol-Myers Squibb (BMY) stake by 97% in Q3 2026, selling an estimated $115K and leaving 62 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #205.
Dunhill Financial first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,541 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Dunhill Financial held 62 shares of Bristol-Myers Squibb worth $120K as of Q3 2026.
- Dunhill Financial sold 1,827 Bristol-Myers Squibb shares in Q3 2026, an estimated $115K.
- Bristol-Myers Squibb made up 0.02% of Dunhill Financial's portfolio in Q3 2026, its #205 holding.
- Dunhill Financial first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.